Given that subpopulations of CD44+/CD133+ surface marker cells exhibit significant stem cell characteristics and self-renewal capacity (Brown et al., 2015; Brown et al., 2017), we further investigated whether POS could influence CD44+/CD133+ subpopulations in GBM cells. This evidence concerns the gene CD44 and glioblastoma.